SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

01 Sep 2015 Evaluate

Sun Pharmaceutical Industries has informed about a Press Release dated September 01, 2015, titled ‘Sun Pharma announces successful completion of Opiates business acquisition in Australia’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma. Inds. Share Price

1924.00 21.00 (1.10%)
08-Jul-2026 09:29 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.00
Dr. Reddys Labs. 1372.95
Cipla 1467.40
Zydus Lifesciences 1179.30
Lupin 2513.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: